Overview

Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled Asthma

Status:
ACTIVE_NOT_RECRUITING

Trial end date:
2026-03-11

Target enrollment:

Participant gender:

Summary

The goal of this study is to assess and compare the effectiveness of fluticasone furoate/umeclidinium bromide/vilanterol trifenatate (FF/UMEC/VI) with inhaled corticosteroids/long-acting beta-2 agonists (ICS/LABA) in adult participants with uncontrolled asthma

Phase:

PHASE4

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

fluticasone furoate